Effects of a Brief Mindful Parenting Program for Hong Kong Chinese Impacted by Social Unrest
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jun 9, 2020
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Design: With a self-administered screening for depression (PHQ-9), parents with a subclinical cutoff score or above will be eligible to participate in a four-session parent workshop. The same program will be provided in five locations in Hong Kong. A waitlist-control randomised controlled trial will be used to evaluate the outcomes of the program. An estimated 340 parents will be recruited and randomised into an intervention group and a wait-list control group. The sample estimation is based on an expected effect size of .33 for family functioning in the PI's pilot study, with an estimated ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • parents of adolescents at aged between 10 to 21
- • a score of PHQ-9 of 2 or above
- Exclusion Criteria:
- • parents with self-reported psychosis, alcohol or substance abuse, individual or family crisis in last six months
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Herman, Hay-ming LO, PhD
Principal Investigator
Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials